EQS-News: aap Implantate AG / Key word: Interim Report/Corporate Action
After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year
15.02.2024.
EQS-News: After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
EQS-Media / 10.01.2024 / 07:30 CET/CESTWith regard to its innovative antibacterial implant technology, aap was able to successfully accelerate recruitment in the ongoing human clinical trial with the adapted study design in the course of 2023 and has already successfully recruited more than 100 patients by 31 Decemb.
EQS-Media / 10.01.2024 / 07:30 CET/CEST
With regard to its innovative antibacterial implant technology, aap was able to successfully accelerate recruitment in the ongoing human clinical trial.
EQS-News: aap Implantate AG / Key word: Study
Visible acceleration in clinical trial with already more than 60 patients; increase in funding of around EUR 0.4 million.